WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM

Announces commercial focus on BioOxiTM bio-oxidation platform as part of targeted alignment on nearer-term and larger revenue opportunities Reduces number of board members as part of geographic transition as a San Francisco Bay Area-based biotech company SUNNYVALE, Calif., Aug. 24, 2023…

Click here to view original post